Overview

Comparison of the Therapeutic Effects of VR With Zoladex and VR in the Treatment of Cesarean Section Scar Defect

Status:
Not yet recruiting

Trial end date:
2025-02-01

Target enrollment:

Participant gender:

Summary

Zoladex will be used to postpone period after vaginal repair for Cesarean Section Scar Defect（CSD） patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without Zoladex, our group will assess whether delayed period improving the CSD prognosis.

Phase:

N/A

Details

Lead Sponsor:

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Treatments:

Goserelin